Veracyte, Inc.: New Data Suggest Veracyte's Envisia Genomic

Findings presented at the European Respiratory Society International Congress 2022 Veracyte, Inc. (Nasdaq: VCYT) today announced new data suggesting that the Envisia Genomic Classifier (EGC) can

Related Keywords

London , City Of , United Kingdom , California , United States , South San Francisco , Brompton , Medway , Tracy Morris , Shayla Gorman , Twitter , European Respiratory Society International Congress , Nasdaq , Research Use , International Congress , European Respiratory Society , Global Corporate Communications , Veracyte Inc , Envisia Genomic Classifier , Athol Wells , Royal Brompton Hospital , Bill Bulman , Counter Analysis System , Note Regarding Forward Looking Statements , Annual Report , Quarterly Report , Nanostring Technologies , Decipher Prostate Genomic Classifier , Research Use Only , Investor Relations , Veracyte , Data , Uggest , Envisia , Enomic , Classifier , Help , Redict , Disease , Progression , Interstitial , Young , Patients , Reated , Combination , Immunosuppressive , Therapy ,